Plain-English translation of NCT05478694 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โThis trial is evaluating how well several approved ablative therapies work for treating prostate cancer that hasn't spread beyond the prostate gland. These therapies use heat or cold energy to destroy cancer cells and are given as a single outpatient procedure lasting 2โ4 hours. The study will track how effectively the treatment controls cancer and how it affects your quality of life.
While several heat and cold-based treatments are available for prostate cancer, doctors need more detailed information about how well they work, how safe they are, and how they affect patients' daily lives and side effects over time.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will receive one of the approved ablative therapies (using heat or cold to treat the cancer) as your regular medical care. The procedure is done on an outpatient basis and takes 2โ4 hours total, including planning and treatment. After the procedure, you will be followed by the research team to monitor how well the treatment worked, check for any side effects, and assess your quality of life over time.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
United States
Enrollment target
~225 participants
Started
February 2023
Primary completion
August 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years โ 90 Years
Sex
Male only
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Sonobia Garrett
University of Texas Southwestern Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.